Progestins and medical treatment of endometriosis – Physiology, history and society

References

• Vercellini P, Cortesi I, Crosignani PG. Progestins for symptomatic endometriosis: a critical analysis of the evidence. Fertil Steril 1997;68:393–401.
   PubMed Web of Science ®Google Scholar
• Killick S, Eyong E, Elstein M. Ovarian follicular development in oral contraceptive cycles. Fertil Steril 1987;48:409–413.
   PubMed Web of Science ®Google Scholar
• Blacker C, Senet JM, Dubourg D, Denis-Rigaud C, Fourtillan JB. Action de la promegestone à la dose de 0 ;500 mg/jour, vingt jours par mois sur le pic ovulatoire de LH. Horm Reprod Metab 1986;3:277–282.
   Google Scholar
• Pelissier C, Blacker C, Feinstein MC, Cournot A, Denis C. Action anti-ovulatoire de l'acétate de chlormadinone. Contracept Fertil Sex 1994;22:37–40.
   PubMedGoogle Scholar
• Bazin B, Thomas Jl, Du Boucher Pincet E, Thebault J. Etude de l'acétate de nomegestrol sur la morphologie et la physiologie folliculaires, relation effet-dose. 9è Congrès français d'Endocrinologie. Strasbourg Ann Endocrinol 1989;50:348.
   Google Scholar
• Kutten F, Moufarege A, Mauvais-Jarvis P. Bases hormonales de la contraception progestative discontinue. Nouv Presse Med 1978;7:3109–3113.
   Google Scholar
• Brosens I. L' Endométriose: une maladie parce qu'elle s'accompagne d'une hémorragie cyclique in Endométriose, 2ème éd, Masson: J Belaisch Coord; 2003. pp 241–248.
   Google Scholar
• Kistner RW. Newer synthetic progestins for the treatment of endometriosis. Prog Gynecol 1970;5:283–302.
   Google Scholar
• Cosson M, Querleu D, Donnez J, Madelenat P, Konincks P, Audebert A, Manhes H. Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study. Fertil Steril 2002;77:684–692.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Vendola N, Bocciolone L, Colombo A, Rognoni MT, Bolis G. Laparoscopic aspiration of ovarian endometriomas. Effect with postoperative gonadotropin releasing hormone agonist treatment. J Reprod Med 1992;37:577–580.
   PubMed Web of Science ®Google Scholar
• Schindler AE. Gonadotropin-releasing hormone agonists for prevention of postoperative adhesions: an overview. Gynecol Endocrinol 2004;19:51–55.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Frontino G, Degiorgi O, Pietropaolo G, Pasin R. Continuous use for an oral contraceptive for endometriosis associated recurrent dysmenorrhoea that does not respond to a cyclic pill regimen. Fertil Steril 2003;80:560–563.
   PubMed Web of Science ®Google Scholar
• Fabre A, Fournier A, Mesrine S, Desreux J, Gompel A, Boutron-Ruault MC, Clavel-Chapelon F. Oral progestagens before menopause and breast cancer risk. Br J Cancer 2007;96:841–844.
   PubMed Web of Science ®Google Scholar
• Bahamondes L, Bahamondes MV, Monteiro I. Levonorgestrel-releasing intrauterine system: uses and controversies. Expert Rev Med Devices 2008;5:437–445.
   PubMed Web of Science ®Google Scholar
• Schlaff D, Luciano A, Crosignani PG. DMPA-SC 104 significantly improves quality of life in women with endometriosis-associated pain: results from 2 randomized clinical trials. Eur J Obstet Gynecol 2005;123(Suppl 1):S9, 04.5.
   Google Scholar
• Amsterdam LL, Gentry W, Jobanputra S, Wolf M, Rubin SD, Bulun SE. Anastrazole and oral contraceptives: a novel treatment for endometriosis. Fertil Steril 2005;84:300–304.
   PubMed Web of Science ®Google Scholar
• Remorgida V, Abbamonte LH, Ragni N, Fulcheri E, Ferrero S. Letrozole and desogestrel-only contraceptive pill for the treatment of stage IV endometriosis. Aust NZ J Obstet Gynaecol 2007;47:222–225.
   PubMed Web of Science ®Google Scholar
• Lefebvre-Lacoeuille C, Catala L, Descamps Ph. Récidives endométriosiques prise en charge et fertilité ultérieure. Reprod Hum Horm 2006;XIX:405–414.
   Google Scholar
• Busacca M, Chiaffarino F, Candiani M, Vignali M, Bertulessi C, Oggioni G, Parazzini F. Determinants of long-term clinically detected recurrence rates of deep, ovarian, and pelvic endometriosis. Am J Obstet Gynecol 2006;195:426–432.
   PubMed Web of Science ®Google Scholar
• Yap C, Furness S, Farquhar C. Pre and post operative medical therapy for endometriosis surgery. Cochrane Database Syst Rev 2008;(3): CD003678.
   Google Scholar
• Vercellini P, Somigliana E, Daguati R, Vigano P, Meroni F, Crosignani PG. Postoperative oral contraceptive exposure and risk of endometrioma recurrence. Am J Obstet Gynecol 2008;198:504.e1–e5.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Frontino G, Degiorgi O, Aimi G, Zaina B. Comparison of a levonorgestrel releasing intrauterine device versus expectant management after conservatrice surgery for symptomatic endometriosis: a pilot study. Fertil Steril 2003;80:305–309.
   PubMed Web of Science ®Google Scholar
• Loverro G, Carriero C, Rossi AC, Putignano G, Nicolardi V, Selvaggi L. A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III–IV endometriosis. Eur J Obstet Gynecol Reprod Biol 2008;136:194–198.
   PubMed Web of Science ®Google Scholar
• Jee BC, Lee JY, Suh CS, Kim SH, Choi YM, Moon SY. Impact of GnRH agonist treatment on recurrence of ovarian endometriomas after conservative laparoscopic surgery. Fertil Steril 2009;91:40–45.
   PubMed Web of Science ®Google Scholar
• Sulak PJ, Carl J, Gopalakrishnan I, Coffee A, Kuehl TJ. Outcomes of extended oral contraceptive regimens with a shortened hormone-free interval to manage breakthrough bleeding. Contraception 2004;70:281–287.
   PubMed Web of Science ®Google Scholar